News for 'Dr Reddys Laboratories'

Dr Reddy's gets USFDA nod for glimepiride

Dr Reddy's gets USFDA nod for glimepiride

Rediff.com10 Oct 2005

Hyderabad based Dr Reddy's Laboratories has received approval from the US Food and Drugs Administration for multiple strengths of anti-diabetes drug glimepiride tablets.

Dr Reddy's, Ranbaxy among best in Asia

Dr Reddy's, Ranbaxy among best in Asia

Rediff.com26 Mar 2003

Indian pharmaceutical majors Dr Reddy's Laboratories and Ranbaxy Labs have made it to the list of 105 best pharmaceutical companies in Asia.

Dr Reddy's founder, chairman Anji Reddy is no more

Dr Reddy's founder, chairman Anji Reddy is no more

Rediff.com15 Mar 2013

Dr. K. Anji Reddy, Founder and Chairman of Dr. Reddy's Laboratories, died at a hospital in Hyderabad on Friday. He was 72.

Dr Reddy's expands its US horizon

Dr Reddy's expands its US horizon

Rediff.com29 Nov 2010

Already having a deal with GlaxoSmithKline for marketing its products in various emerging markets, Dr Reddy's Laboratories had this week inked an agreement to buy the latter's oral penicillin manufacturing facility at Tennessee in the United States.

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Rediff.com16 Sep 2020

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India, RDIF and Dr Reddy's said in a joint statement.

Dr Reddy's to form JV with Fujifilm Corporation

Dr Reddy's to form JV with Fujifilm Corporation

Rediff.com28 Jul 2011

Dr Reddy's Laboratories today said it will form a joint venture with Fujifilm Corporation to develop, manufacture and market generic drugs in Japan.

New urology drug by Dr Reddy's

New urology drug by Dr Reddy's

Rediff.com3 Jul 2006

Dr Reddy's Laboratories Ltd has introduced a drug Alfuzosin Hydrochloride available in extended release tablets of 10 mg dosage.

Dr Reddy's net profit up 7.4%, lags estimates

Dr Reddy's net profit up 7.4%, lags estimates

Rediff.com30 Jul 2013

The Hyderabad-based drugmaker said consolidated net profit rose to Rs Rs 361 crore (Rs 3.61 billion) for the fiscal first quarter ended June, from Rs 336 crore (Rs 3.36 billion) a year earlier.

Dr Reddy's to sell Torrent drugs in Russia

Dr Reddy's to sell Torrent drugs in Russia

Rediff.com30 Nov 2006

Torrent Pharma, the pharmaceuticals major, has entered into a pact with Dr Reddy's Laboratories for exclusive commercialisation of two of its brands in Russia.

Dr Reddy's files suit against Pfizer

Dr Reddy's files suit against Pfizer

Rediff.com24 Feb 2003

Dr Reddy's Laboratories Ltd filed a lawsuit seeking declaratory judgement against Pfizer in United States District Court for the District of New Jersey regarding its Abbreviated New Drug Application for Sertraline HCl.

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Rediff.com15 May 2021

Dr Reddy's Laboratories on Friday soft-launched imported COVID-19 vaccine Sputnik V, with Deepak Sapra, a senior executive of the drug-maker, taking the first shot in Hyderabad.

Dr Reddy's files for generic Allegra in US

Dr Reddy's files for generic Allegra in US

Rediff.com26 Mar 2003

Indian drugmaker Dr Reddy's Laboratories Ltd said on Wednesday it has filed with the US Food and Drug Administration to market a generic version of Aventis Pharmaceuticals' anti-allergy drug Allegra.

Dr Reddy's unveils Proscar in US

Dr Reddy's unveils Proscar in US

Rediff.com21 Jun 2006

Hyderabad-based Dr Reddy's Laboratory said on Wednesday it has launched the generic version of Merck & Co's prostate cancer drug Proscar in the US market after the expiry of its patent.

Dr Reddy's net up 94% at Rs 90.91 crore

Dr Reddy's net up 94% at Rs 90.91 crore

Rediff.com29 Oct 2005

Dr Reddy's Laboratories on Saturday reported a 93.79 per cent increase in consolidated net profit at Rs 90.91 crore (Rs 909.1 million) for the second quarter ended September 30, 2005

Dr Reddy's launches generic Parkinson's disease tablets in US

Dr Reddy's launches generic Parkinson's disease tablets in US

Rediff.com7 Jun 2012

The tablets are bio equivalent generic version of GlaxoSmithKline's Requip XL tablets

Dr Reddy's launch generic version of Xyzal in US

Dr Reddy's launch generic version of Xyzal in US

Rediff.com28 Mar 2011

Hyderabad, Mar 28 (PTI) Dr Reddy's Laboratories Limited has launched Levocetirizine tablets (5mg), a bio-equivalent generic version of Xyzal tablets in the USA market, the company said on Monday.

Dr Reddy's bets big on drug discovery

Dr Reddy's bets big on drug discovery

Rediff.com23 Jul 2008

Dr Reddy's Laboratories hopes to become a true drug discovery company in the near future, said chairman K Anji Reddy and chief executive officer GV Prasad at the 24th annual general body meeting in Hyderabad on Tuesday.

Novartis stops work on Dr Reddy's insulin drug

Novartis stops work on Dr Reddy's insulin drug

Rediff.com23 Jan 2003

Dr Reddy's Laboratories said on Thursday Novartis has decided to stop further work on an anti-diabetes compound licensed to the Swiss drug maker, the second time in six months that a foreign partner has halted development of the Indian firm's drugs.

Dr Reddy's may launch three new drugs in US

Dr Reddy's may launch three new drugs in US

Rediff.com9 Mar 2011

According to Dr Reddy's, the drugmaker may launch Rivastigmine, an anti-mild-to-moderate Alzheimer's drug, Desloratadine, used to treat allergies and Pseudoephedrine, a nasal/sinus decongestant.

Dr Reddy's dilutes suit against Glaxo

Dr Reddy's dilutes suit against Glaxo

Rediff.com5 May 2004

In a bid to speed up the litigation process, the leading home-grown pharma company Dr Reddy's Laboratories has withdrawn its challenge against GlaxoSmithKline's "compound" patent for anti-nausea drug Zofran.

Dr Reddy's to set up two SEZs

Dr Reddy's to set up two SEZs

Rediff.com21 May 2007

Dr Reddy's Laboratories is setting up two special economic zones -- one each at Hyderabad and Visakhapatnam in Andhra Pradesh.

Dr Reddy's recalls Risperidone tablets in US

Dr Reddy's recalls Risperidone tablets in US

Rediff.com16 Apr 2010

Pharma major Dr Reddys Laboratories has voluntarily recalled 78,876 bottles of 2mg and 4mg Risperidone, generic version of Resperdal, tablets in the United States.

Dr Reddy's files second NDA in US

Dr Reddy's files second NDA in US

Rediff.com27 Jun 2003

Dr Reddy's starts 1st clinical trial in Europe

Dr Reddy's starts 1st clinical trial in Europe

Rediff.com7 Feb 2005

Dr Reddy's Laboratories on Monday said it has, for the first time, started testing a drug in Europe with the initiation of Phase I clinical trials for its cardiovascular drug candidate RUS 3108 in Belfast, Ireland.

US stops launch of Dr Reddy's drug

US stops launch of Dr Reddy's drug

Rediff.com14 Jun 2010

Dr Reddy's Laboratories received a major setback in the US, as a court there granted a motion seeking a preliminary injunction to block the launch of its generic version of Sanofi-Aventis' anti-allergic drug, Allegra D24.

Dr Reddy's gets USFDA nod for Amlodipine

Dr Reddy's gets USFDA nod for Amlodipine

Rediff.com7 Apr 2006

Dr Reddy's Laboratories Ltd on Friday said it has received tentative approval from US Food and Drug Administration for amlodipine besylate tablets.

Dr Reddy's to start MBA for staff

Dr Reddy's to start MBA for staff

Rediff.com8 Aug 2005

Pharma major Dr Reddy's Laboratories, on Monday said it will offer MBA programme in pharma management for its employees in association with Narsee Monjee Institute of Management Studies, Mumbai.

Dr Reddy's asked to clarify on sponsoring doctors

Dr Reddy's asked to clarify on sponsoring doctors

Rediff.com5 Apr 2010

The Drug Controller General of India (DCGI) has sought clarification from pharma majors Dr Reddy's Laboratories and Mumbai-based Piramal Healthcare, for allegedly sponsoring doctors for conferences.

Dr Reddy's launch generic cancer drug in US market

Dr Reddy's launch generic cancer drug in US market

Rediff.com12 Jul 2013

The company has launched the Decitabine for injection in the strength of 50 mg in the US market following approval by the United States Food & Drug Administration of Dr Reddy's abbreviated new drug applications, it said in a statement.

Dr Reddy's get FDA nod for Ciprofloxacin

Dr Reddy's get FDA nod for Ciprofloxacin

Rediff.com10 Jun 2004

Dr Reddy's Laboratories Limited announced on Thursday that the United States Food and Drug Administration has issued final approval for the company's abbreviated New Drug Application for Ciprofloxacin tablets 100 mg, 250 mg, 500 mg and 750 mg.

Dr Reddy's signs pact with Russia's R-Pharm

Dr Reddy's signs pact with Russia's R-Pharm

Rediff.com22 Dec 2010

The collaboration will work on a profit sharing model and entail licensing of manufacturing know-how of products by DRL, local manufacturing of products in Russia, co-development of high technology products and knowledge sharing between both parties at regular intervals.